Eight lessons from 2 years of use of the Post-COVID-19 Functional Status scale

Cindy M M de Jong; Y N Jenny Le; Gudula J A M Boon; Stefano Barco; Frederikus A Klok; Bob Siegerink

doi:10.1183/13993003.00416-2023

Eight lessons from 2 years of use of the Post-COVID-19 Functional Status scale

Eur Respir J. 2023 May 18;61(5):2300416. doi: 10.1183/13993003.00416-2023. Print 2023 May.

Authors

Cindy M M de Jong¹, Y N Jenny Le², Gudula J A M Boon¹, Stefano Barco^{3

4}, Frederikus A Klok¹, Bob Siegerink⁵

Affiliations

¹ Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
² Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
³ Department of Angiology, University Hospital Zurich, Zurich, Switzerland.
⁴ Center for Thrombosis and Hemostasis, University Hospital Mainz, Mainz, Germany.
⁵ Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands [email protected].

Abstract

Based on the literature and users’ experiences, lessons could be learned after 2 years’ use of the Post-COVID-19 Functional Status (PCFS) scale, that could contribute to its optimal use. All in all, the PCFS scale provided added value during the pandemic. https://bit.ly/3KkI5Ak

Publication types

Letter

MeSH terms

COVID-19*
Functional Status
Humans